# Frontline of ASCT in High-risk DLBCL

> **NCT05831865** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 175 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05831865
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2025-04-27
- **Final completion:** 2027-04-27
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05831865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05831865, "Frontline of ASCT in High-risk DLBCL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05831865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*